US EditionMiniMed announces closing of Initial Public Offering
MiniMed raised $538 million in net proceeds from its IPO while Medtronic retains 90.03% ownership and repaid intercompany debt with part of the funds.
- MiniMed Group, Inc. began trading its IPO on March 6, 2026, and closed the offering of 28,000,000 shares at $20.00 each.
- The offering generated roughly $538 million in net proceeds, with MiniMed allocating funds for general corporate purposes and repaying intercompany debt to Medtronic plc .
- Post-IPO trading showed shares at $18.00, below the $20.00 IPO price and the 200-day moving average of $18.49, with volume 1,944,976 trailing the 20-day average of 8,820,910.
- Public float concentration may constrain immediate liquidity for MMED shares as Medtronic owns approximately 90.03%, and investors will watch trading within the initial $18.25–$20.4823 range.
- MiniMed, a global insulin-delivery leader, operates in 80 countries and completed its IPO with underwriting support from Goldman Sachs, BofA Securities, and Morgan Stanley & Co.
15 Articles
15 Articles
The Union Democrat
MiniMed announces closing of Initial Public Offering
NORTHRIDGE, Calif., March 9, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED) today announced the closing of its previously announced initial public offering (IPO) of 28,000,000 shares of its common stock at a price to the public of $20.00…
MiniMed completes $560M IPO, Medtronic separation takes shape
MiniMed (Nasdaq:MMED) announced today that it completed its previously announced initial public offering (IPO). Shares of MMED began trading on Friday, March 6, following the pricing of the IPO that day. They closed today, March 9, down 2.7% at $18 apiece. The Medtronic Diabetes unit priced its IPO at $20 per share, offering 28 million shares of common stock, amounting to $560 million. With the addition of an option to purchase more shares, the …
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
